fcrn

J&J Won the First-Ever Drug Approval for Warm Autoimmune Hemolytic Anemia. It Helped About One in Four Patients.

It works by starving rogue antibodies of the recycling route that keeps them alive. Whether it beats the drugs doctors already reach for is the question the first-ever headlines skip.